CIK 0000715446
- Non-accelerated filer
- Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 112622630
- Phone
- +1 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- Open-market buys, last 90 days
- $291,587
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$291,587. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-05 | Gottschalk Emily Director | Grant or award · Employee Stock Option | +25,000 | 25,000 | ||
| 2025-01-02 | Gottschalk Emily Director | Grant or award · Employee Stock Option | +25,000 | 25,000 | ||
| 2024-01-12 | Gottschalk Emily Director | Grant or award · Employee Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2023-01-03 | Gottschalk Emily Director | Grant or award · Employee Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-03-10 | Gottschalk Emily Director | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-07-15 | Gottschalk Emily Director | Purchase | +20,065 | $3.96 | $79K | 45,665 |
| 2021-06-01 | Gottschalk Emily Director | Grant or award · Employee Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2021-04-23 | Gottschalk Emily Director | Purchase | +10,000 | $4.49 | $45K | 25,600 |
| 2021-03-25 | Gottschalk Emily Director | Purchase | +15,600 | $4.88 | $76K | 15,600 |
| 2020-08-13 | Gottschalk Emily Director | Grant or award · Employee Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2019-10-23 | Gottschalk Emily Director | Grant or award · Employee Stock Option (Right to Buy) | +45,000 | 45,000 |
Page 1 of 1 · 11 trades